In March 2025, the company announced new plans for a direct-to-purchaser presenting of its Wegovy weight loss drug. The company founded a fresh pharmacy, called NovoCare, which might cost clients $499 per 30 days for use of the drug, lower than 50 percent the price of the drug by means of other pharmaceutical distribution networks.[fifty three]Note